1. Home
  2. COPR vs PDSB Comparison

COPR vs PDSB Comparison

Compare COPR & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Idaho Copper Corporation Common Stock

COPR

Idaho Copper Corporation Common Stock

HOLD

Current Price

$1.18

Market Cap

60.1M

Sector

N/A

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.90

Market Cap

63.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COPR
PDSB
Founded
2010
2005
Country
United States
United States
Employees
N/A
21
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.1M
63.2M
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
COPR
PDSB
Price
$1.18
$0.90
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
★ $15.38
$4.50
AVG Volume (30 Days)
70.4K
★ 5.6M
Earning Date
12-01-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 28.16
EPS
★ N/A
N/A
Revenue
★ $609,174.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.05
$0.20
52 Week High
$4.16
$1.79

Technical Indicators

Market Signals
Indicator
COPR
PDSB
Relative Strength Index (RSI) 22.37 42.19
Support Level N/A $0.60
Resistance Level $3.63 $1.00
Average True Range (ATR) 0.22 0.17
MACD 0.00 -0.07
Stochastic Oscillator 12.37 17.60

Price Performance

Historical Comparison
COPR
PDSB

About COPR Idaho Copper Corporation Common Stock

Idaho Copper Corp is a USA-based company focused on exploring and developing its copper-molybdenum-silver deposit in Idaho, known as the CuMo project. The CuMo project currently consists of several federal unpatented lode mining claims and various patented mining claims. The unpatented lode mining claims and patented claims are situated in an unorganized mining district, in Boise County, Idaho, spanning Sections in Township 7N and 8N, Range 5E and 6E, Boise Meridian.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

Share on Social Networks: